Improved treatment options for colorectal cancer could be on the horizon

Researchers at the USC Norris Comprehensive Cancer Center found that identifying a metastatic colorectal cancer patient’s Consensus Molecular Subtype (CMS) could help oncologists determine the most effective course of treatment. CMS also had prognostic value, meaning each subgroup was indicative of a patient’s overall survival, regardless of therapy. The results are from the multi-center Phase III trial and published in the Journal of Clinical Oncology.

https://keck.usc.edu/improved-treatment-options-for-colorectal-cancer-could-be-on-the-horizon/

3 Likes